Home / Biotechnology / Direct-to-Consumer Genetic Testing Market By Channel (Direct sales, Retail sales, Doctors office), Business Model (Genome data bank material model, Individual health planning model, Comprehensive genome tests model, Medical precision tests model, Restricted trait tests model) - Growth, Share, Opportunities & Competitive Analysis, 2016 - 2022

Direct-to-Consumer Genetic Testing Market By Channel (Direct sales, Retail sales, Doctors office), Business Model (Genome data bank material model, Individual health planning model, Comprehensive genome tests model, Medical precision tests model, Restricted trait tests model) - Growth, Share, Opportunities & Competitive Analysis, 2016 - 2022

Published: May 2016 | Report Code: 57820-05-16

Direct-to-Consumer (DTC) genetic testing services refer to direct sale of genomic testing to consumers for scrutiny of their personal genome data. DTC genetic testing represents a potent instrument for offering inclusive genomic information to a multitude of individuals, with increasing involvement of physicians or health counselors to help interpreted test results. Consumers can now purchase a range of services based on genome and data, that were previously available for institutional purposes only.

The global direct-to-consumer genetic testing market is in developmental phase and features a handful of players, thus this report attempts at studying the DTC genetic testing market in terms of service types offered by and business models of such notable players, thus presenting the current market dynamics. This report excludes the genomic test offerings employed for treatment purposes. Based on service types this market is categorized into direct sales, retail and doctor's office sales segments. The business model based segmentation of the global DTC genetic testing market is for genome data bank material, individual health planning, comprehensive genome tests, medical precision tests and restricted trait tests models. This report provides market size and forecast for the mentioned segments for the period 2014-2022 with respective CAGR % for the period 2016-2022, considering 2015 as the base year.

Geographically, the global direct-to-consumer genetic testing market is studied for the following regional markets:

  1. North America
  2. Europe
  3. Asia-Pacific
  4. Middle East and Africa
  5. Latin America

The market size and forecast for the period 2014-2022 along with the CAGRs for the period 2016-2022 are also provided in this report.

Qualitative information such as drivers, challenges and future prospects for the global DTC genetic testing market are provided in this study. Tools such as fractal map analysis and attractive investment proposition are presented in this study for scrutinizing competition of the global DTC genetic testing market. This study concludes with company profiles section that highlights information about the key companies engaged in development, manufacture and provision of direct-to-consumer testing solutions.

Direct-to-Consumer Genetic Testing Market

Chapter 1 Preface
1.1 Report Description
1.2 Market Segmentation
1.3 Research Methodology

Chapter 2 Executive Summary
2.1 Direct-to-Consumer Genetic Testing Market Share, by Channel, 2015 (Value %)
2.2 Direct-to-Consumer Genetic Testing Market, by Business Model, 2015 (USD Mn)
2.3 Direct-to-Consumer Genetic Testing Market Share, by Geography, 2015 (Value %)

Chapter 3 Direct-to-Consumer Genetic Testing Market: Market Dynamics and Outlook
3.1 Introduction, Facts and Figures
3.2 Drivers
3.3 Challenges
3.4 Future Prospects
3.5 Attractive Investment Proposition
3.1 Competitive Analysis: Fractal Map Investigation, by Key Market Players

Chapter 4 Global Direct-to-Consumer Genetic Testing Market Analysis, by Channel
4.1 Preface
4.2 Direct Sales
4.3 Retail Sales
4.4 Doctor's Office

Chapter 5 Global Direct-to-Consumer Genetic Testing Market Analysis, by Business Model
5.1 Preface
5.2 Genome Data Bank Material
5.3 Individual Health Planning
5.4 Comprehensive Genome Tests
5.5 Medical Precision Tests
5.6 Restricted Trait Tests

Chapter 6 Global Direct-to-Consumer Genetic Testing Market, by Geography
6.1 Preface
6.2 North America
6.3 Europe
6.4 Asia-Pacific
6.5 Middle East and Africa (MEA)
6.6 Latin America

Chapter 7 Company Profiles
7.1 deCODEme
7.1.1 Business Description
7.1.2 Financial Health and Budget Allocation
7.1.3 Product Positions/Portfolio
7.1.4 News Coverage
7.2 Navigenics
7.2.1 Business Description
7.2.2 Financial Health and Budget Allocation
7.2.3 Product Positions/Portfolio
7.2.4 News Coverage
7.3 23andMe
7.3.1 Business Description
7.3.2 Financial Health and Budget Allocation
7.3.3 Product Positions/Portfolio
7.3.4 News Coverage
7.4 MD Revolution
7.4.1 Business Description
7.4.2 Financial Health and Budget Allocation
7.4.3 Product Positions/Portfolio
7.4.4 News Coverage
7.5 GeneByGene
7.5.1 Business Description
7.5.2 Financial Health and Budget Allocation
7.5.3 Product Positions/Portfolio
7.5.4 News Coverage
7.6 DNA DTC
7.6.1 Business Description
7.6.2 Financial Health and Budget Allocation
7.6.3 Product Positions/Portfolio
7.6.4 News Coverage
7.7 Genetrainer
7.7.1 Business Description
7.7.2 Financial Health and Budget Allocation
7.7.3 Product Positions/Portfolio
7.7.4 News Coverage
7.8 Myriad Genetics
7.8.1 Business Description
7.8.2 Financial Health and Budget Allocation
7.8.3 Product Positions/Portfolio
7.8.4 News Coverage
7.9 Genecodebook Oy
7.9.1 Business Description
7.9.2 Financial Health and Budget Allocation
7.9.3 Product Positions/Portfolio
7.9.4 News Coverage
7.10 Others
7.10.1 Business Description
7.10.2 Financial Health and Budget Allocation
7.10.3 Product Positions/Portfolio
7.10.4 News Coverage

List of Figures

FIG. 1 Direct-to-Consumer Genetic Disease Testing: Market Segmentation
FIG. 2 Direct-to-Consumer Genetic Testing Market Share, by Channel, 2015 (Value %)
FIG. 3 Direct-to-Consumer Genetic Testing Market, by Business Model, 2015 (USD Mn)
FIG. 4 Direct-to-Consumer Genetic Testing Market Share, by Geography, 2015 (Value %)
FIG. 5 Attractive Investment Proposition, Direct-to-Consumer Genetic Testing Market, 2015
FIG. 6 Competitive Analysis: Fractal Map Investigation, by Key Market Players
FIG. 7 Global Direct Sales of DTC Genetic Testing Market, 2014 – 2022 (USD Mn)
FIG. 8 Global Retail Sales of DTC Genetic Testing Market, 2014 – 2022 (USD Mn)
FIG. 9 Global DTC Genetic Testing Market: Sales from Doctor's Office, 2014 – 2022 (USD Mn)
FIG. 10 Global Genome Data Bank Material Market, 2014 – 2022 (USD Mn)
FIG. 11 Global Individual Health Planning Market, 2014 – 2022 (USD Mn)
FIG. 12 Global Comprehensive Genome Tests Market, 2014 – 2022 (USD Mn)
FIG. 13 Global Medical Precision Tests Market, 2014 – 2022 (USD Mn)
FIG. 14 Global Restricted Trait Tests Market, 2014 – 2022 (USD Mn)
FIG. 15 North America Direct-to-Consumer Genetic Testing Market, 2014 – 2022 (USD Mn)
FIG. 16 Europe Direct-to-Consumer Genetic Testing Market, 2014 – 2022 (USD Mn)
FIG. 17 Asia-Pacific Direct-to-Consumer Genetic Testing Market, 2014 – 2022 (USD Mn)
FIG. 18 Middle East and Africa Direct-to-Consumer Genetic Testing Market, 2014 - 2022 (USD Mn)
FIG. 19 Latin America Direct-to-Consumer Genetic Testing Market, 2014 - 2022 (USD Mn)

List of Tables

TABLE 1 Global Direct-to-Consumer Genetic Testing Market, by Channel, 2014 – 2022 (USD Mn)
TABLE 2 Global Direct-to-Consumer Genetic Testing Market, by Business Model, 2014 – 2022 (USD Mn)
TABLE 3 Global Direct-to-Consumer Genetic Testing Market, by Geography, 2014 – 2022 (USD Mn)

Channel Type Segmentation Investigation

Based on sales channel type, global direct-to-consumer genetic testing market is classified as:

1.   Direct sales

2.   Retail sales

3.   Doctors office

Direct-to-Consumer Genetic Testing Market   

Direct sales segment includes services offered directly to the general population without intermediaries between the business and consumer (B2C sales). Most common method is sale of genetic testing kit via internet. Retail sales includes one intermediary where the solution is offered to the customer through retail channel such as pharmacy. Doctor's office channel refers to services offered to the customer/consumer on the instruction or recommendation of physician or medical consultant.

Business Model Segmentation Investigation

Based on the type of business models, global direct-to-consumer genetic testing market categorized into:

1.   Genome data bank material model

2.   Individual health planning model

3.   Comprehensive genome tests model

4.   Medical precision tests model

5.   Restricted trait tests model

Direct-to-Consumer Genetic Testing Market


Genome data bank material model allows the consumers to have their genome fully or partially tested. Parameters of testing include risk of diseases, personality traits, ancestral information and potential risks to medications. Internet is the major purchase source for this model. Individual health planning model refers to health planning on the basis of genome characters and thereby risk to certain chronic diseases, and the fed lifestyle information and personalized guidance to alter lifestyle. Comprehensive genome test model the company offering such solution uses third party genome data, and uses platforms form other genetic testing companies. Genealogy services and lifestyle services are included in this business model type. Medical precision tests model, customers are given solutions to particular issues concerning their health. Interpretation of these test results includes involvement of medical practitioners. Restricted trait tests presents a mix of exclusive tests, where the consumer can opt for tests such as form of lactose intolerance gene, improvement of nutrition, identifying and determining precise exercise regimen and so on.

Based on geographical segmentation, the global direct-to-consumer testing market is studied for:

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

Direct-to-Consumer Testing Market

North America and Europe are the largest markets for direct-to-consumer genetic testing market, due to higher awareness about genetic diseases and the growing proactive tendency among the general public about prevention and efficient management of chronic diseases. Well defined regulatory guidelines about use of genetic testing also plays a critical role in driving the market in these regions. Other Latin America and Asia-Pacific will exhibit the fastest growth in the DTC genetic testing market. Growing awareness and rapid development of healthcare infrastructure in these regions are the prime market drivers.

Due to multitude of hospital admissions, and the growing need for containment of rising morbidity. Stringent guidelines for infection reduction and thus culminating the risk of readmission in hospitals have urged the emerging markets to grow at a rapid CAGR during the forecast period.

Choose License Type
Connect With Us
+1-800-361-8290
24/7 Research Support

Credence Webinars

Join Credence analysts to explore the latest IT Trends

view upcoming webinars

Our Clients